Orphazyme (ORPH) Announces Submission Of Marketing Authorisation Application To EMA

Orphazyme A/S (NASDAQ: ORPH) has revealed Monday that it has submitted Marketing Authorisation Application (MAA) for Arimoclomol to European Medicines Agency (EMA). Arimoclomol is the investigational candidate of Orphazyme for the treatment of Niemann-Pick disease Type C (NPC).

Marketing Authorisation Application is an application lodged by the companies to gain the approval of authorities to bring a particular medicinal product in the market. FDA is currently involved in the review of Orphazyme’s arimoclomol.

If the company receives approval for Arimoclomol then it will be a major breakthrough for Orphazyme as the company is striving to gain the approval of Arimoclomol in major markets.

Furthermore, Arimoclomol has received the Orphan Drug Designation in the US and Europe. It has also received the Breakthrough Therapy Designations as well as FDA Fast Track Designation for Niemann-Pick disease Type C (NPC) in the US. Additionally, Orphazyme has also been awarded Rare Pediatric Disease Designations in the US for Arimoclomol.

Shares of Orphazyme A/S (NASDAQ: ORPH) went down 0.73% at $9.49 during the trading session of Friday. The company had a trading volume of 17.81K as compared to the average volume of 194.46K. In the past 52-weeks of trading, Orphazyme’s stock has changed between the 52-weeks low range of $8.89 and a high range of $11.07.

Furthermore, it has moved up 6.75% from its 52-weeks low and moved up -14.27% from its 52-weeks high. This company has a total market capitalization of $329.28 million at the time of writing.

Niemann-Pick Type C is a rare fatal neurovisceral disease. In this progressive disease person’s body is unable to transport Cholesterol and other fatty substances inside of the cell. NPC basically belongs to the family known as lysosomal storage diseases. Orphazyme has created the investigational drug Arimoclomol which improves the function of lysosomes in the body.

Related Articles

Why Ayro (NASDAQ: AYRO) Stock Is Crashing Today?

Shares of Ayro Inc. (NASDAQ: AYRO) plummeted by 23.49% during the trading session on Tuesday. The firm has disclosed that it has completed the...

Amazon (NASDAQ: AMZN) Join Hands With Federal Watchdog To Stop Counterfeits

Amazon.com, Inc. (NASDAQ: AMZN) has disclosed today that it has teamed up with the National Intellectual Property Rights Coordination Center (IPR Center), a counterfeit...

Goldfield Corporation (GV) Signs Merger Agreement With First Reserve

The Goldfield Corporation (AMEX: GV) has signed a merger agreement with First Reserve. The merger agreement has allowed the affiliate of First Reserve to...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Why Ayro (NASDAQ: AYRO) Stock Is Crashing Today?

Shares of Ayro Inc. (NASDAQ: AYRO) plummeted by 23.49% during the trading session on Tuesday. The firm has disclosed that it has completed the...

Amazon (NASDAQ: AMZN) Join Hands With Federal Watchdog To Stop Counterfeits

Amazon.com, Inc. (NASDAQ: AMZN) has disclosed today that it has teamed up with the National Intellectual Property Rights Coordination Center (IPR Center), a counterfeit...

Goldfield Corporation (GV) Signs Merger Agreement With First Reserve

The Goldfield Corporation (AMEX: GV) has signed a merger agreement with First Reserve. The merger agreement has allowed the affiliate of First Reserve to...

Here’s Why Sundial Growers (NASDAQ: SNDL) Stock Soaring Today?

Shares of Sundial Growers Inc. (NASDAQ: SNDL) has surged 34.55% with heavy volume during the trading session of Tuesday. It has recorded a trading...

Siyata Mobile (NASDAQ: SYTA) Announces Distribution Agreement With pei tel

Siyata Mobile Inc. (NASDAQ: SYTA) announced it has entered into a distribution agreement with pei tel Communications GmbH, a distributor based in Germany, for...